![Lauren Hartle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lauren Hartle
Private Equity Analist bij Prime Impact Fund
Actieve functies van Lauren Hartle
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Prime Impact Fund
![]() Prime Impact Fund Investment ManagersFinance Prime Impact Fund (Prime Impact) is a venture capital firm founded in 2018 by Johanna Wolfson and Matthew Nordan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Analist | 01-06-2020 | - |
Loopbaan van Lauren Hartle
Eerdere bekende functies van Lauren Hartle
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AlphaVax, Inc.
![]() AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01-02-2008 | 01-06-2009 |
Opleiding van Lauren Hartle
Harvard University | Doctorate Degree |
University of North Carolina System | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Doctorate Degree | 1 |
Private Equity Analyst | 1 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Prime Impact Fund
![]() Prime Impact Fund Investment ManagersFinance Prime Impact Fund (Prime Impact) is a venture capital firm founded in 2018 by Johanna Wolfson and Matthew Nordan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
AlphaVax, Inc.
![]() AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
- Beurs
- Insiders
- Lauren Hartle
- Ervaring